
David Planchard/oncostream.com
May 10, 2025, 17:56
David Planchard discussed EGFR-mutated NSCLC and clinical research developments with chinese colleagues
David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at thr Gustave Roussy, shared a post on LinkedIn:
“A moment of exchange this morning with my Chinese colleagues on EGFR-mutated NSCLC patients.
Thank you for the invitation and the quality of the discussions! Clinical research continues for our patients with many new molecules on the way, I hope…”
More posts featuring David Planchard on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023